NDC product
Fexofenadine Hydrochloride
NDC 0904-7050 · Major Pharmaceuticals
Key facts
| Product NDC | 0904-7050 |
|---|---|
| Proprietary name | Fexofenadine Hydrochloride |
| Nonproprietary name | Fexofenadine HCl |
| Substances | FEXOFENADINE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Major Pharmaceuticals |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA204507 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | Nov 29, 2019 |
| Marketing end | Oct 28, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory